Sustainable Insight Capital Management LLC Acquires 1,700 Shares of Colgate-Palmolive (NYSE:CL)

Sustainable Insight Capital Management LLC boosted its stake in Colgate-Palmolive (NYSE:CLFree Report) by 37.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,300 shares of the company’s stock after buying an additional 1,700 shares during the quarter. Sustainable Insight Capital Management LLC’s holdings in Colgate-Palmolive were worth $611,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CL. Union Savings Bank increased its stake in shares of Colgate-Palmolive by 76.6% during the 4th quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. purchased a new stake in Colgate-Palmolive in the second quarter valued at approximately $25,000. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $32,000. PSI Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 4,971.4% in the 1st quarter. PSI Advisors LLC now owns 355 shares of the company’s stock worth $32,000 after purchasing an additional 348 shares in the last quarter. Finally, Core Wealth Advisors Inc. grew its position in Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after acquiring an additional 146 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $107.90 on Friday. Colgate-Palmolive has a one year low of $67.62 and a one year high of $109.30. The stock has a market cap of $88.53 billion, a price-to-earnings ratio of 34.15, a price-to-earnings-growth ratio of 3.73 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The stock has a 50 day moving average price of $101.07 and a 200-day moving average price of $94.45.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business’s revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.77 earnings per share. Equities analysts expect that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a $0.50 dividend. The ex-dividend date was Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 1.85%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CL shares. Deutsche Bank Aktiengesellschaft boosted their target price on Colgate-Palmolive from $104.00 to $107.00 and gave the company a “buy” rating in a research note on Monday, July 29th. BNP Paribas started coverage on Colgate-Palmolive in a report on Monday, June 24th. They set an “outperform” rating and a $109.00 target price on the stock. Argus boosted their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Finally, Jefferies Financial Group downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Eight investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $102.53.

Check Out Our Latest Report on CL

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares in the company, valued at $1,069,868.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,490 shares of company stock valued at $4,486,063. Company insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.